Use of cookies
Cookies help us to provide our services. By using our website you agree that we can use cookies. Read more about our Privacy Policy and visit the following link: Privacy Policy (only in German)
2018.10.17
Active substance: hydrochlorothiazide
Marketing authorisation holders of the products containing hydrochlorothiazide would like to inform about pharmacoepidemiological studies which have shown a risk of non-melanoma skin cancer (NMSC) (basal cell carcinoma, squamous cell carcinoma) with exposure to increasing cumulative doses of hydrochlorothiazide (HCTZ).
Download DHPC / Information letter , Download_VeroeffentlichtAm_EN